$5.55
+
$0.25 (4.72%)
End-of-day quote: 02/20/2024
NasdaqGM:CLGN
CollPlant Biotechnologies Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $154.64 | $174.55 | 0.00% | 3 | $372.17B |
| ABBV | AbbVie | NYSE | Outperform | $166.42 | $178.42 | 0.00% | 11 | $293.88B |
| SYK | Stryker Corp | NYSE | Outperform | $334.68 | $353.16 | 0.00% | 24 | $127.50B |
| COLO B | Coloplast A/S | CPSE | Hold | kr850.00 | kr812.28 | 0.00% | 5 | kr191.11B |
| ZBH | Zimmer Biomet Holdings | NYSE | Hold | $120.18 | $132.52 | 0.00% | 1 | $24.72B |
| SN. | Smith & Nephew | LSE | Outperform | £10.24 | £16.09 | 0.00% | 10 | £8.73B |
| CTEC | ConvaTec Group PLC | LSE | Outperform | £2.55 | £3.43 | 0.00% | 6 | £5.45B |
| IART | Integra LifeSciences Holdings | NasdaqGS | Hold | $27.54 | $46.60 | 0.00% | 4 | $1.82B |
| ORGO | Organogenesis Holdings | NasdaqCM | Outperform | $2.74 | $4.75 | 0.00% | 1 | $401.69M |
| BICO | BICO Group AB (publ) | OM | Buy | kr43.88 | kr135.00 | 0.00% | 1 | kr2.64B |
